Olives and bone: A green osteoporosis prevention option

International Journal of Environmental Research and Public Health

Volumn 13, Issue 8, 2016, Pages

  Chin, Kok Yong ^a   Ima Nirwana, Soelaiman ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Menopause; Oleuropein; Olives; Polyphenol; Skeleton; Tyrosol

Indexed keywords

OLIVE OIL; OLIVE POLYPHENOL DERIVATIVE; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG; POLYPHENOL;

BONE; DIET; ELDERLY POPULATION; PHENOLIC COMPOUND; PUBLIC HEALTH; SKELETON; VEGETABLE OIL;

AGING; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BIOMECHANICS; BONE DENSITY; BONE STRENGTH; BONE TURNOVER; CELL DIFFERENTIATION; CELL PROLIFERATION; DIET SUPPLEMENTATION; DIET THERAPY; EVIDENCE BASED MEDICINE; FOOD COMPOSITION; HUMAN; IN VITRO STUDY; INFLAMMATION; NONHUMAN; NUTRITIONAL HEALTH; OLIVE; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; OXIDATIVE STRESS; REVIEW; TREATMENT RESPONSE; ANIMAL; CHEMISTRY; DIET; DRUG EFFECTS; OLIVE TREE;

ANIMALIA; OLEACEAE; RATTUS;

ANIMALS; BONE DENSITY; DIET; HUMANS; OLEA; OLIVE OIL; OSTEOPOROSIS; POLYPHENOLS;

EID: 84979647967     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13080755     Document Type: Review

References (45)

1. Edwards, M.H.; Dennison, E.M.; Aihie Sayer, A.; Fielding, R.; Cooper, C. Osteoporosis and sarcopenia in older age. Bone 2015, 80, 126-130. [CrossRef] [PubMed]
2. Johnell, O.; Kanis, J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos. Int. 2006, 17, 1726-1733. [CrossRef] [PubMed]
3. Gullberg, B.; Johnell, O.; Kanis, J.A. World-wide projections for hip fracture. Osteoporos. Int. 1997, 7, 407-413. [CrossRef] [PubMed]
4. Feng, X.; McDonald, J.M. Disorders of bone remodeling. Ann. Rev. Pathol. 2011, 6, 121-145. [CrossRef] [PubMed]
5. Manolagas, S.C. From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr. Rev. 2010, 31, 266-300. [CrossRef] [PubMed]
6. Ginaldi, L.; Di Benedetto, M.C.; De Martinis, M. Osteoporosis, inflammation and ageing. Immun. Ageing 2005, 2, 14. [CrossRef] [PubMed]
7. Riggs, B.L.; Khosla, S.; Melton, L.J. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 2002, 23, 279-302. [CrossRef] [PubMed]
8. McLean, R.R. Proinflammatory cytokines and osteoporosis. Curr. Osteoporos. Rep. 2009, 7, 134-139. [CrossRef] [PubMed]
9. Bjarnason, I.; Macpherson, A.; Mackintosh, C.; Buxton-Thomas, M.; Forgacs, I.; Moniz, C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997, 40, 228-233. [CrossRef] [PubMed]
10. Bernstein, C.N.; Blanchard, J.F.; Leslie, W.; Wajda, A.; Yu, B.N. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann. Intern. Med. 2000, 133, 795-799. [CrossRef] [PubMed]
11. Ha, H.; Bok Kwak, H.; Woong Lee, S.; Mi Jin, H.; Kim, H.-M.; Kim, H.-H.; Hee Lee, Z. Reactive oxygen species mediate rank signaling in osteoclasts. Exp. Cell Res. 2004, 301, 119-127. [CrossRef] [PubMed]
12. Fatokun, A.A.; Stone, T.W.; Smith, R.A. Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species. Eur. J. Pharmacol. 2008, 587, 35-41. [CrossRef] [PubMed]
13. Sharma, T.; Islam, N.; Ahmad, J.; Akhtar, N.; Beg, M. Correlation between bone mineral density and oxidative stress in postmenopausal women. Indian J. Endocrinol. Metab. 2015, 19, 491-497. [PubMed]
14. Cervellati, C.; Bonaccorsi, G.; Cremonini, E.; Bergamini, C.M.; Patella, A.; Castaldini, C.; Ferrazzini, S.; Capatti, A.; Picarelli, V.; Pansini, F.S.; et al. Bone mass density selectively correlates with serum markers of oxidative damage in post-menopausal women. Clin. Chem. Lab. Med. 2013, 51, 333-338. [CrossRef] [PubMed]
15. Chin, K.Y.; Ima-Nirwana, S. The biological effects of tocotrienol on bone: A review on evidence from rodent models. Drug Des. Dev. Ther. 2015, 9, 2049-2061. [CrossRef] [PubMed]
16. Chin, K.-Y.; Mo, H.; Soelaiman, I.-N. A review of the possible mechanisms of action of tocotrienol—A potential antiosteoporotic agent. Curr. Drug Targets 2013, 14, 1533-1541. [CrossRef] [PubMed]
17. Peddada, K.V.; Peddada, K.V.; Shukla, S.K.; Mishra, A.; Verma, V. Role of curcumin in common musculoskeletal disorders: A review of current laboratory, translational, and clinical data. Orthop. Surg. 2015, 7, 222-231. [CrossRef] [PubMed]
18. Mangano, K.M.; Sahni, S.; Kerstetter, J.E.; Kenny, A.M.; Hannan, M.T. Polyunsaturated fatty acids and their relation with bone and muscle health in adults. Curr. Osteoporos. Rep. 2013, 11, 203-212. [CrossRef] [PubMed]
19. Benetou, V.; Orfanos, P.; Pettersson-Kymmer, U.; Bergstrom, U.; Svensson, O.; Johansson, I.; Berrino, F.; Tumino, R.; Borch, K.B.; Lund, E.; et al. Mediterranean diet and incidence of hip fractures in a european cohort. Osteoporos. Int. 2013, 24, 1587-1598. [CrossRef] [PubMed]
20. Seiquer, I.; Mesias, M.; Hoyos, A.M.; Galdo, G.; Navarro, M.P. A mediterranean dietary style improves calcium utilization in healthy male adolescents. J. Am. Coll. Nutr. 2008, 27, 454-462. [CrossRef] [PubMed]
21. Fernández-Real, J.M.; Bulló, M.; Moreno-Navarrete, J.M.; Ricart, W.; Ros, E.; Estruch, R.; Salas-Salvadó, J. A mediterranean diet enriched with olive oil is associated with higher serum total osteocalcin levels in elderly men at high cardiovascular risk. J. Clin. Endocrinol. Metab. 2012, 97, 3792-3798. [CrossRef] [PubMed]
22. Ostrowska, E.; Gabler, N.K.; Ridley, D.; Suster, D.; Eagling, D.R.; Dunshea, F.R. Extra-virgin and refined olive oils decrease plasma triglyceride, moderately affect lipoprotein oxidation susceptibility and increase bone density in growing pigs. J. Sci. Food Agric. 2006, 86, 1955-1963. [CrossRef]
23. Rezq, A.A.; Labib, F.A.; Attia, A.E.M. Effect of some dietary oils and fats on serum lipid profile, calcium absorption and bone mineralization in mice. Pakistan J. Nutr. 2010, 9, 643-650. [CrossRef]
24. Tuck, K.L.; Hayball, P.J. Major phenolic compounds in olive oil: Metabolism and health effects. J. Nutr. Biochem. 2002, 13, 636-644. [CrossRef]
25. Efentakis, P.; Iliodromitis, E.K.; Mikros, E.; Papachristodoulou, A.; Dagres, N.; Skaltsounis, A.L.; Andreadou, I. Effects of the olive tree leaf constituents on myocardial oxidative damage and atherosclerosis. Planta Med. 2015, 81, 648-654. [CrossRef] [PubMed]
26. Puel, C.; Mardon, J.; Kati-Coulibaly, S.; Davicco, M.J.; Lebecque, P.; Obled, C.; Rock, E.; Horcajada, M.N.; Agalias, A.; Skaltsounis, L.A.; et al. Black lucques olives prevented bone loss caused by ovariectomy and talc granulomatosis in rats. Br. J. Nutr. 2007, 97, 1012-1020. [CrossRef] [PubMed]
27. Puel, C.; Quintin, A.; Agalias, A.; Mathey, J.; Obled, C.; Mazur, A.; Davicco, M.J.; Lebecque, P.; Skaltsounis, A.L.; Coxam, V. Olive oil and its main phenolic micronutrient (oleuropein) prevent inflammation-induced bone loss in the ovariectomised rat. Br. J. Nutr. 2004, 92, 119-127. [CrossRef] [PubMed]
28. Saleh, N.K.; Saleh, H.A. Olive oil effectively mitigates ovariectomy-induced osteoporosis in rats. BMC Complement. Altern. Med. 2011, 11, 10. [CrossRef] [PubMed]
29. Liu, H.; Huang, H.; Li, B.; Wu, D.; Wang, F.; Zheng, X.H.; Chen, Q.; Wu, B.; Fan, X. Olive oil in the prevention and treatment of osteoporosis after artificial menopause. Clin. Interv. Aging 2014, 9, 2087-2095. [CrossRef] [PubMed]
30. Soler-Rivas, C.; Espín, J.C.; Wichers, H.J. Oleuropein and related compounds. J. Sci. Food Agric. 2000, 80, 1013-1023. [CrossRef]
31. Puel, C.; Mardon, J.; Agalias, A.; Davicco, M.J.; Lebecque, P.; Mazur, A.; Horcajada, M.N.; Skaltsounis, A.L.; Coxam, V. Major phenolic compounds in olive oil modulate bone loss in an ovariectomy/inflammation experimental model. J. Agric. Food. Chem. 2008, 56, 9417-9422. [CrossRef] [PubMed]
32. Puel, C.; Mathey, J.; Agalias, A.; Kati-coulibaly, S.; Mardon, J.; Obled, C.; Davicco, M.J.; Lebecque, P.; Horcajada, M.N.; Skaltsounis, A.L.; et al. Dose-response study of effect of oleuropein, an olive oil polyphenol, in an ovariectomy/inflammation experimental model of bone loss in the rat. Clin. Nutr. 2006, 25, 859-868. [CrossRef] [PubMed]
33. Hagiwara, K.; Goto, T.; Araki, M.; Miyazaki, H.; Hagiwara, H. Olive polyphenol hydroxytyrosol prevents bone loss. Eur. J. Pharmacol. 2011, 662, 78-84. [CrossRef] [PubMed]
34. Keiler, A.M.; Zierau, O.; Bernhardt, R.; Scharnweber, D.; Lemonakis, N.; Termetzi, A.; Skaltsounis, L.; Vollmer, G.; Halabalaki, M. Impact of a functionalized olive oil extract on the uterus and the bone in a model of postmenopausal osteoporosis. Eur. J. Nutr. 2014, 53, 1073-1081. [CrossRef] [PubMed]
35. García-Martínez, O.; Mazzaglia, G.; Sánchez-Ortiz, A.; Ocaña-Peinado, F.M.; Rivas, A. Phenolic content of sicilian virgin olive oils and their effect on MG-63 human osteoblastic cell proliferation. Grasas Aceites 2014, 65, e032.
36. Garcia-Martinez, O.; De Luna-Bertos, E.; Ramos-Torrecillas, J.; Ruiz, C.; Milia, E.; Lorenzo, M.L.; Jimenez, B.; Sanchez-Ortiz, A.; Rivas, A. Phenolic compounds in extra virgin olive oil stimulate human osteoblastic cell proliferation. PLoS ONE 2016, 11, e0150045. [CrossRef] [PubMed]
37. Santiago-Mora, R.; Casado-Diaz, A.; De Castro, M.D.; Quesada-Gomez, J.M. Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: The effect on differentiation in stem cells derived from bone marrow. Osteoporos. Int. 2011, 22, 675-684. [CrossRef] [PubMed]
38. Mazzanti, L.; Battino, M.; Nanetti, L.; Raffaelli, F.; Alidori, A.; Sforza, G.; Carle, F.; Quagliarini, V.; Cester, N.; Vignini, A. Effect of 1-year dietary supplementation with vitaminized olive oil on markers of bone turnover and oxidative stress in healthy post-menopausal women. Endocrine 2015, 50, 326-334. [CrossRef] [PubMed]
39. Gundberg, C.M.; Lian, J.B.; Booth, S.L. Vitamin k-dependent carboxylation of osteocalcin: Friend or foe? Adv. Nutr. 2012, 3, 149-157. [CrossRef] [PubMed]
40. Rossouw, J.E.; Anderson, G.L.; Prentice, R.L.; LaCroix, A.Z.; Kooperberg, C.; Stefanick, M.L.; Jackson, R.D.; Beresford, S.A.; Howard, B.V.; Johnson, K.C.; et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women’s health initiative randomized controlled trial. JAMA 2002, 288, 321-333. [PubMed]
41. Kuiper, G.G.; Lemmen, J.G.; Carlsson, B.; Corton, J.C.; Safe, S.H.; van der Saag, P.T.; van der Burg, B.; Gustafsson, J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139, 4252-4263. [PubMed]
42. Holt, G.; Smith, R.; Duncan, K.; Hutchison, J.D.; Gregori, A. Gender differences in epidemiology and outcome after hip fracture: Evidence from the scottish hip fracture audit. Bone Jt. J. 2008, 90-B, 480-483. [CrossRef] [PubMed]
43. Penrod, J.D.; Litke, A.; Hawkes, W.G.; Magaziner, J.; Doucette, J.T.; Koval, K.J.; Silberzweig, S.B.; Egol, K.A.; Siu, A.L. The association of race, gender, and comorbidity with mortality and function after hip fracture. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2008, 63, 867-872. [CrossRef]
44. Lelovas, P.P.; Xanthos, T.T.; Thoma, S.E.; Lyritis, G.P.; Dontas, I.A. The laboratory rat as an animal model for osteoporosis research. Comp. Med. 2008, 58, 424-430. [PubMed]
45. Turner, A.S. Animal models of osteoporosis—Necessity and limitations. Eur. Cells Mater. 2001, 1, 66-81.